BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+5.01%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$531M
AUM Growth
+$531M
(-3.6%)
Cap. Flow
-$34.6M
Cap. Flow
% of AUM
-6.51%
Top 10 Holdings %
Top 10 Hldgs %
30.22%
Holding
139
New
9
Increased
20
Reduced
40
Closed
15
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$8.11M |
| 2 |
ABMD
Abiomed Inc
ABMD
|
$6.25M |
| 3 |
Stryker
SYK
|
$6.23M |
| 4 |
AMSG
Amsurg Corp
AMSG
|
$5.74M |
| 5 |
Hologic
HOLX
|
$5.44M |
Top Sells
| 1 |
Becton Dickinson
BDX
|
$6.99M |
| 2 |
Gilead Sciences
GILD
|
$6.41M |
| 3 |
Supernus Pharmaceuticals
SUPN
|
$5.64M |
| 4 |
Biogen
BIIB
|
$5.33M |
| 5 |
STJ
St Jude Medical
STJ
|
$4.84M |
Sector Composition
| 1 | Healthcare | 92.67% |
| 2 | Financials | 0.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SHPG
26
DELISTED
Shire pic
SHPG
| $7.15M | 1.35% |
38,850
+4,970
| +15% | +$915K |
|
27
Edwards Lifesciences
EW
$47.7B
| $6.78M | 1.28% |
68,000
-5,000
| -7% | -$499K |
|
|
ABMD
28
DELISTED
Abiomed Inc
ABMD
| $6.25M | 1.18% |
+57,200
| New | +$6.25M |
|
29
Cigna
CI
$80.2B
| $6.14M | 1.16% |
48,000
| – | – |
|
30
Johnson & Johnson
JNJ
$429B
| $6.07M | 1.14% |
50,000
| – | – |
|
|
BCR
31
DELISTED
CR Bard Inc.
BCR
| $5.88M | 1.11% |
25,000
| – | – |
|
|
ALXN
32
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $5.77M | 1.09% |
49,400
| – | – |
|
|
AMSG
33
DELISTED
Amsurg Corp
AMSG
| $5.74M | 1.08% |
+74,000
| New | +$5.74M |
|
34
Vertex Pharmaceuticals
VRTX
$102B
| $5.68M | 1.07% |
66,000
| – | – |
|
35
Humana
HUM
$37.5B
| $5.4M | 1.02% |
30,000
| – | – |
|
36
Viatris
VTRS
$12.3B
| $5.18M | 0.97% |
119,700
-100,300
| -46% | -$4.34M |
|
37
Coherus Oncology, Inc. Common Stock
CHRS
$146M
| $5.14M | 0.97% |
304,000
+17,000
| +6% | +$287K |
|
38
BioMarin Pharmaceuticals
BMRN
$11.3B
| $5.06M | 0.95% |
65,000
| – | – |
|
|
ESRX
39
DELISTED
Express Scripts Holding Company
ESRX
| $4.93M | 0.93% |
65,000
+6,400
| +11% | +$485K |
|
40
McKesson
MCK
$85.9B
| $4.85M | 0.91% |
26,000
-17,000
| -40% | -$3.17M |
|
|
MDVN
41
DELISTED
MEDIVATION, INC.
MDVN
| $4.7M | 0.88% |
78,000
+15,000
| +24% | +$904K |
|
|
STJ
42
DELISTED
St Jude Medical
STJ
| $4.68M | 0.88% |
60,000
-62,000
| -51% | -$4.84M |
|
43
Cooper Companies
COO
$13.3B
| $4.03M | 0.76% |
23,500
| – | – |
|
44
Perrigo
PRGO
$3.21B
| $3.99M | 0.75% |
44,000
+11,400
| +35% | +$1.03M |
|
45
Masimo
MASI
$7.43B
| $3.94M | 0.74% |
75,000
| – | – |
|
|
ARIA
46
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $3.66M | 0.69% |
495,000
| – | – |
|
|
AKRX
47
DELISTED
Akorn, Inc.
AKRX
| $3.62M | 0.68% |
+127,000
| New | +$3.62M |
|
|
NUVA
48
DELISTED
NuVasive, Inc.
NUVA
| $3.58M | 0.67% |
60,000
| – | – |
|
|
CERN
49
DELISTED
Cerner Corp
CERN
| $3.52M | 0.66% |
60,000
| – | – |
|
50
HCA Healthcare
HCA
$95.4B
| $3.37M | 0.63% |
43,700
-16,300
| -27% | -$1.26M |
|